Join to View Full Profile
3825 Edwards RdSte 300Cincinnati, OH 45209
Phone+1 513-221-1100
Fax+1 513-684-4501
Dr. Curry is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Richard Curry is a medical director at CTI.
Clinical Expertise
- Neuro-oncology
Education & Training
University of Cincinnati Medical Center/College of MedicineResidency, Neurology, 2007 - 2011
The University of Toledo College of MedicineClass of 2007
Certifications & Licensure
KY State Medical License 2014 - 2027
OH State Medical License 2012 - 2027
IN State Medical License 2016 - 2023
NY State Medical License 2011 - 2013
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
Clinical Trials
- A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma Start of enrollment: 2011 Dec 01
Publications & Presentations
PubMed
- 27 citationsXanthogranulomatous epithelial tumor: report of 6 cases of a novel, potentially deceptive lesion with a predilection for young women.Karen J. Fritchie, Jorge Torres-Mora, Carrie Y. Inwards, Khin Thway, Sumathi Vaiyapuri
Modern Pathology. 2020-05-15 - Intracranial Germinoma: Systemic Chemotherapy in Addition to Dose-Reduced Radiation Therapy.Lauren Chiec, Richard Curry, Nagla Abdel Karim
American Journal of Therapeutics. 2017-01-01 - 7 citationsHigh-dose methotrexate-based chemotherapy as treatment for histiocytic sarcoma of the central nervous systemRichard Charles Curry, Geraldine Faivre, Leila Akkari, Johanna A. Joyce, Oscar Lin
Leukemia & Lymphoma. 2016-01-04
Press Mentions
The First Human Trials of This Experimental, Cancer-Killing Drug Could Change EverythingAugust 9th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
